EMA: Guideline on the acceptability of names for human medicinal products processed through the centralised procedure

This 6th update of the guideline further clarifies specific aspects of the criteria applied to address safety and public health concerns, international non-proprietary names issues and product-specific concerns in proposed (invented) names. Also, the procedure for submission of proposed (invented) names requests is streamlined and further clarified.